Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration

Tissue Engineering - Part B: Reviews

Volumn 23, Issue 6, 2017, Pages 515-528

  Fu, Yao ^a   Karbaat, Lisanne ^a   Wu, Ling ^b   Leijten, Jeroen ^a   Both, Sanne K ^a   Karperien, Marcel ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

apoptosis; extracellular vesicles; growth factors; membrane nanotubes; mesenchymal stem cells; trophic effects

Indexed keywords

BIOACTIVITY; CELL CULTURE; CELL DEATH; FLOWCHARTING; NANOTUBES; REPAIR; STEM CELLS; TISSUE; YARN;

BENEFICIAL EFFECTS; CELL BASED THERAPIES; EXTRACELLULAR; GROWTH FACTOR; MESENCHYMAL STEM CELL; PARENCHYMAL CELLS; THERAPEUTIC VALUES; TROPHIC EFFECTS;

TISSUE REGENERATION;

GROWTH FACTOR; MESSENGER RNA; MICRORNA; NANOTUBE;

APOPTOSIS; CARTILAGE INJURY; CELL COMMUNICATION; CELL FUNCTION; CYTOKINE RELEASE; EXOSOME; HEART INFARCTION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; TISSUE REPAIR; TROPHIC ACTIVITY; VASCULARIZATION; WOUND HEALING; ANIMAL; BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASE; CYTOLOGY; MESENCHYMAL STROMA CELL; PHYSIOLOGY; REGENERATION; TISSUE ENGINEERING;

ANIMALS; CARDIOVASCULAR DISEASES; CELL- AND TISSUE-BASED THERAPY; EXTRACELLULAR VESICLES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; REGENERATION; TISSUE ENGINEERING; WOUND HEALING;

EID: 85030144813     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2016.0365     Document Type: Review

References (192)

1. Cancedda, R., Giannoni P., and Mastrogiacomo,M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28, 4240, 2007.
2. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
3. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M., and Yoo, J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238, 265, 1998.
4. Guilak, F., Awad, H.A., Fermor, B., Leddy, H.A., and Gimble, J.M. Adipose-derived adult stem cells for cartilage tissue engineering. Biorheology 41, 389, 2004.
5. Usas, A., and Huard, J. Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 28, 5401, 2007.
6. De Coppi, P., Bartsch, G., Siddiqui, M.M., Xu, T., Santos, C.C., Perin, L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25, 100, 2007.
7. Weiss, M.L., and Troyer, D.L. Stem cells in the umbilical cord. Stem Cell Rev 2, 155, 2006.
8. Caplan, A.I. Cell delivery and tissue regeneration. J Control Release 11, 157, 1990.
9. Caplan, A.I. Mesenchymal stem cells. J Orthop Res 9, 641, 1991.
10. Caplan, A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11, 1198, 2005.
11. Buda, R., Vannini, F., Cavallo, M., Baldassarri, M., Luciani, D., Mazzotti, A., et al. One-step arthroscopic technique for the treatment of osteochondral lesions of the knee with bone-marrow-derived cells: three years results. Musculoskelet Surg 97, 145, 2013.
12. Chen, W., Liu, J., Manuchehrabadi, N., Weir, M.D., Zhu, Z., and Xu, H.H.K. Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects. Biomaterials 34, 9917, 2013.
13. Haleem, A.M., Singergy, A.A., Sabry, D., Atta, H.M., Rashed, L.A., Chu, C.R., et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 1, 253, 2010.
14. Jung, K.H., Shin, H.P., Lee, S., Lim, Y.J., Hwang, S.H., Han, H., et al. Effect of human umbilical cord bloodderived mesenchymal stem cells in a cirrhotic rat model. Liver Int 29, 898, 2009.
15. Oksuz, S., Ulkur, E., Oncul, O., Kose, G.T., Kucukodaci, Z., and Urhan, M. The effect of subcutaneous mesenchymal stem cell injection on statis zone and apoptosis in an experimental burn model. Plast Reconstr Surg 131, 463, 2013.
16. van Ramshorst, J., Bax, J.J., Beeres, S.L., Dibbets-Schneider, P., Roes, S.D., Stokkel, M.P., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 301, 1997, 2009.
17. Devine, S.M., Bartholomew, A.M., Mahmud, N., Nelson, M., Patil, S., Hardy, W., et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 29, 244, 2001.
18. Ji, J.F., He, B.P., Dheen, S.T., and Tay, S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22, 415, 2004.
19. Lange, C., Brunswig-Spickenheier, B., Cappallo-Obermann, H., Eggert, K., Gehling, U.M., Rudolph, C., et al. Radiation rescue: mesenchymal stromal cells protect from lethal irradiation. PLoS One 6, e14486, 2011.
20. Shi, M., Li, J., Liao, L., Chen, B., Li, B., Chen, L., et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 92, 897, 2007.
21. Yang, X., Balakrishnan, I., Torok-Storb, B., and Pillai, M.M. Marrow stromal cell infusion rescues hematopoiesis in lethally irradiated mice despite rapid clearance after infusion. Adv Hematol 2012, 142530, 2012.
22. Terrovitis, J.V., Smith, R.R., and Marban, E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 106, 479, 2010.
23. Muller-Ehmsen, J., Krausgrill, B., Burst, V., Schenk, K., Neisen, U.C., Fries, J.W., et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41, 876, 2006.
24. Kang, S.K., Lee, D.H., Bae, Y.C., Kim, H.K., Baik, S.Y., and Jung, J.S. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 183, 355, 2003.
25. Mora-Lee, S., Sirerol-Piquer, M.S., Gutierrez-Perez, M., Gomez-Pinedo, U., Roobrouck, V.D., Lopez, T., et al. Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One 7, e43683, 2012.
26. Moon, M.H., Kim, S.Y., Kim, Y.J., Kim, S.J., Lee, J.B., Bae, Y.C., et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 17, 279, 2006.
27. Gnecchi, M., Zhang, Z., Ni, A., and Dzau, V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103, 1204, 2008.
28. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
29. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838, 2002.
30. English, K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91, 19, 2013.
31. Klinker, M.W., and Wei, C.H. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 7, 556, 2015.
32. Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24, 386, 2006.
33. Nasef, A., Chapel, A., Mazurier, C., Bouchet, S., Lopez, M., Mathieu, N., et al. Identification of IL-10 and TGFbeta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 13, 217, 2007.
34. Nasef, A., Mathieu, N., Chapel, A., Frick, J., Francois, S., Mazurier, C., et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84, 231, 2007.
35. Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26, 212, 2008.
36. Sun, L., Cui, M., Wang, Z., Feng, X., Mao, J., Chen, P., et al. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun 357, 779, 2007.
37. Spanholtz, T.A., Theodorou, P., Holzbach, T., Wutzler, S., Giunta, R.E., and Machens, H.G. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network-a future therapy for ischemically challenged tissue. J Surg Res 171, 329, 2011.
38. Rehman, J., Traktuev, D., Li, J., Merfeld-Clauss, S., Temm-Grove, C.J., Bovenkerk, J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109, 1292, 2004.
39. Kinnaird, T., Stabile, E., Burnett, M.S., Lee, C.W., Barr, S., Fuchs, S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94, 678, 2004.
40. Beckermann, B.M., Kallifatidis, G., Groth, A., Frommhold, D., Apel, A., Mattern J., et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99, 622, 2008.
41. Mirotsou, M., Zhang, Z., Deb, A., Zhang, L., Gnecchi, M., Noiseux, N., et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104, 1643, 2007.
42. Imberti, B., Morigi, M., Tomasoni, S., Rota, C., Corna, D., Longaretti, L., et al. Insulin-like growth factor-1 sustains stem cell-mediated renal repair. J Am Soc Nephrol 18, 2921, 2007.
43. Dufourcq, P., Descamps, B., Tojais, N.F., Leroux, L., Oses, P., Daret, D., et al. Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells 26, 2991, 2008.
44. Block, G.J., Ohkouchi, S., Fung, F., Frenkel, J., Gregory, C., Pochampally, R., et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27, 670, 2009.
45. Kuchroo, P., Dave, V., Vijayan, A., Viswanathan, C., and Ghosh, D. Paracrine factors secreted by umbilical cordderived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev 24, 437, 2015.
46. Kim, Y., Kim, H., Cho, H., Bae, Y., Suh, K., and Jung, J. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 20, 867, 2007.
47. Morigi, M., and De Coppi, P. Cell therapy for kidney injury: different options and mechanisms-mesenchymal and amniotic fluid stem cells. Nephron Exp Nephrol 126, 59, 2014.
48. Wakabayashi, K., Nagai, A., Sheikh, A.M., Shiota, Y., Narantuya, D., Watanabe, T., et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 88, 1017, 2010.
49. Gnecchi, M., He, H., Noiseux, N., Liang, O.D., Zhang, L., Morello, F., et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20, 661, 2006.
50. Newman, R.E., Yoo, D., LeRoux, M.A., and Danilkovitch-Miagkova, A. Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8, 110, 2009.
51. Caplan, A.I., and Dennis, J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98, 1076, 2006.
52. Kassis, I., Vaknin-Dembinsky, A., and Karussis, D. Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection. Curr Stem Cell Res Ther 6, 63, 2011.
53. Chen, L., Tredget, E.E., Wu, P.Y., and Wu, Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PloS one 3, e1886, 2008.
54. Gurtner, G.C., Werner, S., Barrandon, Y., and Longaker, M.T. Wound repair and regeneration. Nature 453, 314, 2008.
55. Ochs, B.G., Muller-Horvat, C., Albrecht, D., Schewe, B., Weise, K., Aicher, W. K., et al. Remodeling of articular cartilage and subchondral bone after bone grafting and matrix-associated autologous chondrocyte implantation for osteochondritis dissecans of the knee. Am J Sports Med 39, 764, 2011.
56. Hendriks, J.A., Miclea, R.L., Schotel, R., de Bruijn, E., Moroni, L., Karperien, M., et al. Primary chondrocytes enhance cartilage tissue formation upon co-culture with a range of cell types. Soft Matter 6, 5080, 2010.
57. Vadala, G., Studer, R.K., Sowa, G., Spiezia, F., Iucu, C., Denaro, V., et al. Coculture of bone marrow mesenchymal stem cells and nucleus pulposus cells modulate gene expression profile without cell fusion. Spine (Phila Pa 1976) 33, 870, 2008.
58. Nakamura, T., Sekiya, I., Muneta, T., Hatsushika, D., Horie, M., Tsuji, K., et al. Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs. Cytotherapy 14, 327, 2012.
59. Baraniak, P.R., and McDevitt T. C. Stem cell paracrine actions and tissue regeneration. Regen Med 5, 121, 2010.
60. Meirelles Lda, S., Fontes, A.M., Covas, D.T., and Caplan, A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20, 419, 2009.
61. Wu, L., Leijten, J.C., Georgi, N., Post, J.N., van Blitterswijk, C.A., and Karperien, M. Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. Tissue Eng Part A 17, 1425, 2011.
62. Fujihara, Y., Takato, T., and Hoshi K. Macrophageinducing FasL on chondrocytes forms immune privilege in cartilage tissue engineering, enhancing in vivo regeneration. Stem Cells 32, 1208, 2014.
63. Xie, G.H., Wang, S.J., Wang, Y., Zhang, Y., Zhang, H.Z., Jin, S., et al. Fas Ligand gene transfer enhances the survival of tissue-engineered chondrocyte allografts in minipigs. Transpl Immunol 19, 145, 2008.
64. Acharya, C., Adesida, A., Zajac, P., Mumme, M., Riesle, J., Martin, I., et al. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol 227, 88, 2012.
65. Meretoja, V.V., Dahlin, R.L., Kasper, F.K., and Mikos, A.G. Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials 33, 6362, 2012.
66. Wang, M., Rahnama, R., Cheng, T., Grotkopp, E., Jacobs, L., Limburg, S., et al. Trophic stimulation of articular chondrocytes by late-passage mesenchymal stem cells in coculture. J Orthop Res 31, 1936, 2013.
67. Wu, L., Prins, H.-J., Helder, M.N., van Blitterswijk, C.A., and Karperien,M. Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng Part A 18, 1542, 2012.
68. Dahlin, R.L., Kinard, L.A., Lam, J., Needham, C.J., Lu, S., Kasper, F.K., et al. Articular chondrocytes and mesenchymal stem cells seeded on biodegradable scaffolds for the repair of cartilage in a rat osteochondral defect model. Biomaterials 35, 7460, 2014.
69. de Windt, T.S., Vonk, L.A., Slaper-Cortenbach, I.C., van den Broek, M.P., Nizak, R., van Rijen, M.H., et al. Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons. Stem Cells 35, 256, 2017.
70. Morigi, M., Imberti, B., Zoja, C., Corna, D., Tomasoni, S., Abbate, M., et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15, 1794, 2004.
71. Duffield, J.S., Park, K.M., Hsiao, L.-L., Kelley, V.R., Scadden, D.T., Ichimura, T., et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115, 1743, 2005.
72. Herrera, M.B., Bussolati, B., Bruno, S., Fonsato, V., Romanazzi, G.M., and Camussi, G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14, 1035, 2004.
73. Choi, S., Park, M., Kim, J., Hwang, S., Park, S., and Lee, Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev 18, 521, 2009.
74. Lange, C., Togel, F., Ittrich, H., Clayton, F., Nolte-Ernsting, C., Zander, A.R., et al. Administered mesenchymal stem cells enhance recovery from ischemia/ reperfusion-induced acute renal failure in rats. Kidney Int 68, 1613, 2005.
75. Humphreys, B.D., and Bonventre, J.V. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 59, 311, 2008.
76. Wise, A.F., and Ricardo, S.D. Mesenchymal stem cells in kidney inflammation and repair. Nephrology (Carlton) 17, 1, 2012.
77. Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange,, C., and Westenfelder, C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289, F31, 2005.
78. Tögel, F., Zhang, P., Hu, Z., and Westenfelder, C. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J Cell Mol Med 13, 2109, 2009.
79. Yagi, H., Soto-Gutierrez, A., Navarro-Alvarez, N., Nahmias, Y., Goldwasser, Y., Kitagawa, Y., et al. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18, 1857, 2010.
80. Bi, B., Schmitt, R., Israilova, M., Nishio, H., and Cantley, L.G. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18, 2486, 2007.
81. Wollert, K.C., and Drexler H. Cell-based therapy for heart failure. Curr Opin Cardiol 21, 234, 2006.
82. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
83. Iso, Y., Spees, J.L., Serrano, C., Bakondi, B., Pochampally, R., Song, Y.-H., et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354, 700, 2007.
84. Hatzistergos, K.E., Quevedo, H., Oskouei, BN., Hu, Q., and Feigenbaum, G.S., Margitich, I. S., et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107, 913, 2010.
85. Crisostomo, P.R., Wang, M., Markel, T.A., Lahm, T., Abarbanell, A.M., Herrmann J. L., et al. Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28, 375, 2007.
86. Van Linthout, S., Savvatis, K., Miteva, K., Peng, J., Ringe, J., Warstat, K., et al. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J 32, 2168, 2011.
87. Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11, 367, 2005.
88. Danieli, P., Malpasso, G., Ciuffreda, M.C., Cervio, E., Calvillo, L., Copes, F., et al. Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis. Stem Cells Transl Med 4, 448, 2015.
89. Lim, B.K., Choi, J.H., Nam, J.H., Gil, C.O., Shin, J.O., Yun, S.H., et al. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc Res 71, 517, 2006.
90. Shabbir, A., Zisa, D., Suzuki, G., and Lee, T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296, H1888, 2009.
91. Pedersen, T.O., Blois, A.L., Xue, Y., Xing, Z., Cottler-Fox, M., Fristad, I., et al. Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells. J Tissue Eng 3, 2041731412443236, 2012.
92. Tateishi-Yuyama, E., Matsubara, H., Murohara, T., Ikeda, U., Shintani, S., Masaki, H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427, 2002.
93. Kinnaird, T., Stabile, E., Burnett, M.S., Shou, M., Lee, C.W., Barr, S., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543, 2004.
94. Kim, W.S., Park, B.S., Sung, J.H., Yang, J.M., Park, S.B., Kwak, S.J., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 48, 15, 2007.
95. Lee, E.Y., Xia, Y., Kim, W.S., Kim, M.H., Kim, T.H., Kim, K.J., et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17, 540, 2009.
96. Hocking, A.M., and Gibran, N.S. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 316, 2213, 2010.
97. Kwon, D.S., Gao, X., Liu, Y.B., Dulchavsky, D.S., Danyluk, A.L., Bansal, M., et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J 5, 453, 2008.
98. Drago, D., Cossetti, C., Iraci N., Gaude, E., Musco G., Bachi, A., et al. The stem cell secretome and its role in brain repair. Biochimie 95, 2271, 2013.
99. Paul, G., Anisimov, S.V. The secretome of mesenchymal stem cells: potential implications for neuroregeneration. Biochimie 95, 2246, 2013.
100. Galindo, L.T., Filippo, T.R., Semedo, P., Ariza, C.B., Moreira, C.M., and Camara, N.O., et al. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int 2011, 564089, 2011.
101. Chen, C.-W., Montelatici, E., Crisan, M., Corselli, M., Huard, J., Lazzari, L., et al. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 20, 429, 2009.
102. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1a. J Cell Physiol 166, 585, 1996.
103. Chen, J., Zhang, Z.G., Li, Y., Wang, L., Xu, Y.X., Gautam, S.C., et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92, 692, 2003.
104. Li, Y., Chen, J., Zhang, C.L., Wang, L., Lu, D., Katakowski, M., et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49, 407, 2005.
105. Quesenberry, P.J., and Aliotta, J.M. The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev 4, 137, 2008.
106. Caplan, A. Why are MSCs therapeutic? New data: new insight. J Pathol 217, 318, 2009.
107. Bhatia, S.N., Yarmush,M.L., and Toner,M. Controlling cell interactions by micropatterning in co-cultures: hepatocytes and 3T3 fibroblasts. J Biomed Mater Res 34, 189, 1997.
108. Gerstenfeld, L., Barnes, G., Shea, C., and Einhorn, T. Osteogenic differentiation is selectively promoted by morphogenetic signals from chondrocytes and synergized by a nutrient rich growth environment. Connect Tissue Res 44, 85, 2003.
109. Aplin, A.E., Howe, A., Alahari, S.K., and Juliano, R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulincell adhesion molecules, and selectins. Pharmacol Rev 50, 197, 1998.
110. Camussi, G., Deregibus, M.C., Bruno, S., Cantaluppi, V., and Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78, 838, 2010.
111. Wei, C. J., Xu, X., and Lo, C.W. Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol 20, 811, 2004.
112. Colombo, M., Raposo, G., and Thery, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30, 255, 2014.
113. Michael, A., Bajracharya, S.D., Yuen, P.S., Zhou, H., Star, R.A., Illei, G.G., et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16, 34, 2010.
114. Pisitkun, T., Shen, R.-F., and Knepper, M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101, 13368, 2004.
115. Keller, S., Rupp, C., Stoeck, A., Runz, S., Fogel, M., Lugert, S., et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int 72, 1095, 2007.
116. van Dommelen, S.M., Vader, P., Lakhal, S., Kooijmans, S.A., van Solinge, W.W., Wood, M.J., et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 161, 635, 2012.
117. Cocucci, E., Racchetti, G., and Meldolesi, J. Shedding microvesicles: artefacts no more. Trends Cell Biol 19, 43, 2009.
118. Keller, S., Sanderson, M.P., Stoeck, A., and Altevogt, P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 107, 102, 2006.
119. Bruno, S., Porta, S., and Bussolati, B. Extracellular vesicles in renal tissue damage and regeneration. Eur J Pharmacol 790, 83, 2016.
120. Heijnen, H.F., Schiel, A.E., Fijnheer, R., Geuze, H.J., and Sixma, J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and-Granules. Blood 94, 3791, 1999.
121. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 495, 2007.
122. Kondo, S. Altruistic cell suicide in relation to radiation hormesis. Int J Radiat Biol Relat Stud Phys Chem Med 53, 95, 1988.
123. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2, ra81, 2009.
124. Gyorgy, B., Szabo, T.G., Pasztoi, M., Pal, Z., Misjak, P., Aradi, B., et al. Membrane vesicles, current state-of-theart: emerging role of extracellular vesicles. Cell Mol Life Sci 68, 2667, 2011.
125. Aliotta, J.M., Pereira, M., Li, M., Amaral, A., Sorokina, A., Dooner, M.S., et al. Stable cell fate changes in marrow cells induced by lung-derived microvesicles. J Extracell Vesicles 1, 2012.
126. Thery, C., Ostrowski, M., and Segura, E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9, 581, 2009.
127. Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P.J., Cihak, J., et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6, 769, 2000.
128. Sarkar, A., Mitra, S., Mehta, S., Raices, R., and Wewers, M.D. Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS One 4, e7140, 2009.
129. Sheldon, H., Heikamp, E., Turley, H., Dragovic, R., Thomas, P., Oon, C.E., et al. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 116, 2385, 2010.
130. Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847, 2006.
131. Kogure, T., Yan, I.K., Lin, W.L., and Patel, T. Extracellular vesicle-mediated Transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer 4, 261, 2013.
132. Chen, X., Liang, H., Zhang, J., Zen, K., and Zhang, C.-Y. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22, 125, 2012.
133. Li, L., and Xie, T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 21, 605, 2005.
134. Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20, 1053, 2009.
135. Wetmore, B.A., Brees, D.J., Singh, R., Watkins, P.B., Andersen, M.E., Loy, J., et al. Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology 51, 2127, 2010.
136. Furuta, T., Miyaki, S., Ishitobi, H., Ogura, T., Kato, Y., Kamei, N., et al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl Med 5, 1620, 2016.
137. Hu, B., Chen, S., Zou, M., He, Z., Shao, S., and Liu, B. Effect of extracellular vesicles on neural functional recovery and immunologic suppression after rat cerebral apoplexy. Cell Physiol Biochem 40, 155, 2016.
138. Kalimuthu, S., Gangadaran, P., Li, X.J., Oh, J.M., Lee, H.W., Jeong, S.Y., et al. In vivo therapeutic potential of mesenchymal stem cell-derived extracellular vesicles with optical imaging reporter in tumor mice model. Sci Rep 6, 30418, 2016.
139. Lai, R.C., Tan, S.S., Teh, B.J., Sze, S.K., Arslan, F., de Kleijn, D.P., et al. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012, 971907, 2012.
140. Montemurro, T., Vigano, M., Ragni, E., Barilani, M., Parazzi, V., Boldrin, V., et al. Angiogenic and antiinflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration. Eur J Cell Biol 95, 228, 2016.
141. Kholia, S., Ranghino, A., Garnieri, P., Lopatina, T., Deregibus, M.C., Rispoli, P., et al. Extracellular vesicles as new players in angiogenesis. Vascul Pharmacol 86, 64, 2016.
142. Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S., Choo, A., Chen, T.S., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4, 214, 2010.
143. Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., and Yu, H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 92, 387, 2014.
144. Kang, K., Ma, R., Cai, W., Huang, W., Paul, C., Liang, J., et al. Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via Akt signaling pathway following myocardial infarction. Stem Cells Int 2015, 659890, 2015.
145. Zhang, G., Wang, D., Miao, S., Zou, X., Liu, G., and Zhu, Y. Extracellular vesicles derived from mesenchymal stromal cells may possess increased therapeutic potential for acute kidney injury compared with conditioned medium in rodent models: a meta-analysis. Exp Ther Med 11, 1519, 2016.
146. Nagaishi, K., Mizue, Y., Chikenji, T., Otani, M., Nakano, M., Konari, N., et al. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep 6, 34842, 2016.
147. Doeppner, T.R., Herz, J., Gorgens, A., Schlechter, J., Ludwig, A.K., Radtke, S., et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med 4, 1131, 2015.
148. Hofer, H.R., and Tuan, R.S. Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies. Stem Cell Res Ther 7, 131, 2016.
149. Maumus, M., Jorgensen, C., and Noel, D. Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95, 2229, 2013.
150. Zhang, S., Chu, W.C., Lai, R.C., Lim, S.K., Hui, J.H., and Toh, W.S. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage 24, 2135, 2016.
151. van Koppen, A., Joles, J.A., van Balkom, B.W., Lim, S.K., de Kleijn, D., Giles, R.H., et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 7, e38746, 2012.
152. Rustom, A., Saffrich, R., Markovic, I., Walther, P., and Gerdes, H.-H. Nanotubular highways for intercellular organelle transport. Science 303, 1007, 2004.
153. Koyanagi, M., Brandes, R.P., Haendeler, J., Zeiher, A.M., and Dimmeler, S. Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes a novel mechanism for cell fate changes? Circ Res 96, 1039, 2005.
154. Watkins, S.C., and Salter, R.D. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 23, 309, 2005.
155. Wang, Y., Cui, J., Sun, X., and Zhang, Y. Tunnelingnanotube development in astrocytes depends on p53 activation. Cell Death Differ 18, 732, 2011.
156. Sowinski, S., Jolly, C., Berninghausen, O., Purbhoo, M.A., Chauveau, A., Köhler, K., et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol 10, 211, 2008.
157. Kwok, R. Cell biology: the new cell anatomy. Nature 480, 26, 2011.
158. Chauveau, A., Aucher, A., Eissmann, P., Vivier, E., and Davis, D.M. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc Natl Acad Sci U S A 107, 5545, 2010.
159. Kimura, S., Hase, K., and Ohno, H. The molecular basis of induction and formation of tunneling nanotubes. Cell Tissue Res 352, 67, 2013.
160. ö nfelt, B., Nedvetzki, S., Benninger, R.K., Purbhoo, M.A., Sowinski, S., Hume, A.N., et al. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J Immunol 177, 8476, 2006.
161. Wang, X., and Gerdes, H.-H. Long-distance electrical coupling via tunneling nanotubes. Biochim Biophys Acta 1818, 2082, 2012.
162. Davis, D.M., and Sowinski, S. Membrane nanotubes: dynamic long-distance connections between animal cells. Nat Rev Mol Cell Biol 9, 431, 2008.
163. Gurke, S., Barroso, J.F., and Gerdes, H.-H. The art of cellular communication: tunneling nanotubes bridge the divide. Histochem Cell Biol 129, 539, 2008.
164. Gerdes, H.-H., and Carvalho, R.N. Intercellular transfer mediated by tunneling nanotubes. Curr Opin Cell Biol 20, 470, 2008.
165. Sherer, N.M., and Mothes, W. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. Trends Cell Biol 18, 414, 2008.
166. Bukoreshtliev, N.V., Wang, X., Hodneland, E., Gurke, S., Barroso, J. F., and Gerdes, H.-H. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Lett 583, 1481, 2009.
167. Wang, X., Veruki, M.L., Bukoreshtliev, N.V., Hartveit, E., and Gerdes H.-H. Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels. Proc Natl Acad Sci U S A 107, 17194, 2010.
168. Galkina, S.I., Stadnichuk, V.I., Molotkovsky, J.G., Romanova, J.M., Sud'ina, G.F., and Klein, T. Microbial alkaloid staurosporine induces formation of nanometer-wide membrane tubular extensions (cytonemes, membrane tethers) in human neutrophils. Cell Adh Migr 4, 32, 2010.
169. Lachambre, S., Chopard, C., and Beaumelle, B. Preliminary characterisation of nanotubes connecting T-cells and their use by HIV-1. Biol Cell 106, 394, 2014.
170. Hase, K., Kimura, S., Takatsu, H., Ohmae, M., Kawano, S., Kitamura, H., et al. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex. Nat Cell Biol 11, 1427, 2009.
171. Spees, J. L., Olson, S.D., Whitney, M.J., and Prockop, D.J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A 103, 1283, 2006.
172. Kadiu, I., and Gendelman, H.E. Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and Golgi network. J Proteome Res 10, 3225, 2011.
173. Rainy, N., Chetrit, D., Rouger, V., Vernitsky, H., Rechavi, O., Marguet, D., et al. H-Ras transfers from B to T cells via tunneling nanotubes. Cell Death Dis 4, e726, 2013.
174. He, K., Shi, X., Zhang, X., Dang, S., Ma, X., Liu, F., et al. Long-distance intercellular connectivity between cardiomyocytes and cardiofibroblasts mediated by membrane nanotubes. Cardiovasc Res 92, 39, 2011.
175. Rinaldo, C.R. HIV-1 trans infection of CD4(+) T cells by professional antigen presenting cells. Scientifica (Cairo) 2013, 164203, 2013.
176. Thayanithy, V., Dickson, E.L., Steer, C., Subramanian, S., and Lou, E. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes. Transl Res 164, 359, 2014.
177. Ferrati, S., Shamsudeen, S., Summers, H.D., Rees, P., Abbey, J.V., Schmulen, J., et al. Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small 8, 3151, 2012.
178. Vallabhaneni, K.C., Haller, H., and Dumler, I. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Stem Cells Dev 21, 3104, 2012.
179. Takahashi, A., Kukita, A., Li, Y.j., Zhang, J.q., Nomiyama, H., Yamaza, T., et al. Tunneling nanotube formation is essential for the regulation of osteoclastogenesis. J Cell Biochem 114, 1238, 2013.
180. Lou, E., Fujisawa, S., Barlas, A., Romin, Y., Manova-Todorova, K., Moore, M.A., et al. Tunneling Nanotubes: a new paradigm for studying intercellular communication and therapeutics in cancer. Commun Integr Biol 5, 399, 2012.
181. Lai, R.C., Chen, T.S., and Lim, S.K. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6, 481, 2011.
182. Wu, L., Leijten, J., van Blitterswijk, C.A., and Karperien, M. Fibroblast growth factor-1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of osteoarthritic chondrocytes in co-culture. Stem Cells Dev 22, 2356, 2013.
183. Asanuma, H., Meldrum, D.R., and Meldrum, K.K. Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 184, 26, 2010.
184. Chen, L., Xu, Y., Zhao, J., Zhang, Z., Yang, R., Xie, J., et al. Conditioned medium from hypoxic bone marrowderived mesenchymal stem cells enhances wound healing in mice. PLoS One 9, e96161, 2014.
185. Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W., and Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation. Blood 103, 4619, 2004.
186. Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109, 228, 2007.
187. Gupta, N., Su, X., Popov, B., Lee, J.W., Serikov, V., and Matthay, M.A. Intrapulmonary delivery of bone marrowderived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179, 1855, 2007.
188. Nasef, A., Mazurier, C., Bouchet, S., Francois, S., Chapel, A., Thierry, D., et al. Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 253, 16, 2008.
189. Spaggiari, G.M., Capobianco, A., Becchetti, S., Mingari, M.C., and Moretta, L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107, 1484, 2006.
190. Nemeth, K., Leelahavanichkul, A., Yuen, P.S., Mayer, B., Parmelee, A., Doi, K., et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15, 42, 2009.
191. Spaggiari, G.M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M.C., and Moretta, L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111, 1327, 2008.
192. English, K., Ryan, J.M., Tobin, L., Murphy, M.J., Barry, F.P., and Mahon, B.P. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 156, 149, 2009.